Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma.
卡瑞利珠单抗联合或不联合自体细胞因子诱导的杀伤细胞治疗难治性透明细胞肾细胞癌的随机试点研究。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-38881-1
Li Shuzhan, Qin Jing, Sun Qian, Zhao Hua, Xiong Yanjuan, Wang Yang, Han Ying, Zhang Jiali, Zhang Weihong, Shen Meng, Yang Fan, Ren Baozhu, Zhou Li, Li Runmei, Hui Zhenzhen, Tian Xiao, Cao Shui, Du Weijiao, Yu Wenwen, Liu Liang, Zhang Xinwei, Ren Xiubao